155 related articles for article (PubMed ID: 27768063)
1. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
Janosko K; Holbrook MR; Adams R; Barr J; Bollinger L; Newton JT; Ntiforo C; Coe L; Wada J; Pusl D; Jahrling PB; Kuhn JH; Lackemeyer MG
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768063
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Positive Pressure Protective Suit for a Biosafety Level 4 Laboratory in Japan.
Shichinohe S; Sakurai Y; Hayasaka D; Yamada E; Shinohara K; Kurosaki Y; Nakajima K
Jpn J Infect Dis; 2023 Mar; 76(2):162-166. PubMed ID: 36575023
[TBL] [Abstract][Full Text] [Related]
3. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.
Mazur S; Holbrook MR; Burdette T; Joselyn N; Barr J; Pusl D; Bollinger L; Coe L; Jahrling PB; Lackemeyer MG; Wada J; Kuhn JH; Janosko K
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768081
[TBL] [Abstract][Full Text] [Related]
4. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology.
Bohannon JK; Janosko K; Holbrook MR; Barr J; Pusl D; Bollinger L; Coe L; Hensley LE; Jahrling PB; Wada J; Kuhn JH; Lackemeyer MG
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768036
[TBL] [Abstract][Full Text] [Related]
5. Maintaining differential pressure gradients does not increase safety inside modern BSL-4 laboratories.
Kurth A; Weber U; Reichenbacher D
Front Bioeng Biotechnol; 2022; 10():953675. PubMed ID: 36110311
[TBL] [Abstract][Full Text] [Related]
6. [Development of a positive pressure protective suit for BSL-4 laboratory].
Shichinohe S
Uirusu; 2022; 72(2):131-138. PubMed ID: 38220157
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the operator protection factors offered by positive pressure air suits against airborne microbiological challenge.
Steward JA; Lever MS
Viruses; 2012 Aug; 4(8):1202-11. PubMed ID: 23012620
[TBL] [Abstract][Full Text] [Related]
8. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures.
Byrum R; Keith L; Bartos C; St Claire M; Lackemeyer MG; Holbrook MR; Janosko K; Barr J; Pusl D; Bollinger L; Wada J; Coe L; Hensley LE; Jahrling PB; Kuhn JH; Lentz MR
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768056
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
[TBL] [Abstract][Full Text] [Related]
10. Biosafety level 3 laboratory for autopsies of patients with severe acute respiratory syndrome: principles, practices, and prospects.
Li L; Gu J; Shi X; Gong E; Li X; Shao H; Shi X; Jiang H; Gao X; Cheng D; Guo L; Wang H; Shi X; Wang P; Zhang Q; Shen B
Clin Infect Dis; 2005 Sep; 41(6):815-21. PubMed ID: 16107979
[TBL] [Abstract][Full Text] [Related]
11. Efficacy Testing of Personal Protective Filters on Biosafety Level 4 Positive Pressure Suits.
Fey G; Leung A; Landry L; Lightly G; Kasloff S; Cutts T; Krishnan J
Appl Biosaf; 2021 Jun; 26(2):66-70. PubMed ID: 36034692
[No Abstract] [Full Text] [Related]
12. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
Shurtleff AC; Garza N; Lackemeyer M; Carrion R; Griffiths A; Patterson J; Edwin SS; Bavari S
Viruses; 2012 Dec; 4(12):3932-51. PubMed ID: 23342380
[TBL] [Abstract][Full Text] [Related]
13. Biosafety Level 4 Laboratory User Training Program, China.
Xia H; Huang Y; Ma H; Liu B; Xie W; Song D; Yuan Z
Emerg Infect Dis; 2019 May; 25(5):. PubMed ID: 31002302
[TBL] [Abstract][Full Text] [Related]
14. Standard practice for cell sorting in a BSL-3 facility.
Perfetto SP; Ambrozak DR; Nguyen R; Roederer M; Koup RA; Holmes KL
Methods Mol Biol; 2011; 699():449-69. PubMed ID: 21116997
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
Mourya DT; Yadav PD; Majumdar TD; Chauhan DS; Katoch VM
Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
[TBL] [Abstract][Full Text] [Related]
16. BSL-3 laboratory practices in the United States: comparison of select agent and non-select agent facilities.
Richards SL; Pompei VC; Anderson A
Biosecur Bioterror; 2014; 12(1):1-7. PubMed ID: 24552359
[TBL] [Abstract][Full Text] [Related]
17. Report of the International Conference on Risk Communication Strategies for BSL-4 laboratories, Tokyo, October 3-5, 2007.
Dickmann P; Keith K; Comer C; Abraham G; Gopal R; Marui E
Biosecur Bioterror; 2009 Jun; 7(2):227-33. PubMed ID: 19635008
[TBL] [Abstract][Full Text] [Related]
18. Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents.
Loibner M; Langner C; Regitnig P; Gorkiewicz G; Zatloukal K
Pathobiology; 2021; 88(1):37-45. PubMed ID: 33296902
[TBL] [Abstract][Full Text] [Related]
19. A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories.
Hughes L; Wilkins K; Goldsmith CS; Smith S; Hudson P; Patel N; Karem K; Damon I; Li Y; Olson VA; Satheshkumar PS
J Virol Methods; 2017 May; 243():68-73. PubMed ID: 28131867
[TBL] [Abstract][Full Text] [Related]
20. Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.
van Soolingen D; Wisselink HJ; Lumb R; Anthony R; van der Zanden A; Gilpin C
Int J Tuberc Lung Dis; 2014 Aug; 18(8):885-9. PubMed ID: 25199000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
